Dyslipidemia Evaluation and Management

Дата публикации: 18-08-2026 00:00:00

This JAMA Clinical Guidelines Synopsis summarizes the 2026 American College of Cardiology (ACC)/American Heart Association (AHA) guideline on management of dyslipidemia.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy	0	11.25	18-08-2026
2	Cardiovascular Risk Reclassification With the 2026 Dyslipidemia Guideline	0	11.38	18-08-2026
3	Prevalence of LDL-C Above 2026 Dyslipidemia Guideline Goals Among US Adults	0	20.18	18-08-2026
4	New Dyslipidemia Guidelines Lower the Lipid Treatment Goals and Raise the Bar for Clinical Practice	0	6.02	18-08-2026
5	Global Burden of Elevated LDL-C	0	10.09	29-07-2026
6	Patient Information: Cyclosporiasis	0	7.35	21-07-2026
7	2026 ACM Conferentie over Reproducibility and Replicability	0	0	20-07-2026
8	Insight Network Summit	0	5	04-06-2026
9	2026 Global Trade and Innovation Policy Alliance Summit	0	10.72	11-09-2026
10	X 2026	0	0	19-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.26. Источник: archderm.jamanetwork.com.